Stay updated with breaking news from Clinical fellow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ASCO 2024 results of a multicenter phase II trial of modified FOLFIRINOX for the first-line treatment of advanced urachal cancer (ULTMA; KCSG GU20-03), Urachal cancer is a rare malignancy accounting for 1% of bladder cancers. ....